Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NextCure Inc NXTC

Healthcare Biotechnology
NextCure, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing medicines that treat cancer patients that do not respond to, or have disease progression on, current therapies, through the use of differentiated mechanisms of actions including Antibody-Drug Conjugates (ADCs), antibodies, and proteins. The Company focuses on advancing therapies that leverage its... see more

Recent & Breaking News (NDAQ:NXTC)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NextCure, Inc. - NXTC

GlobeNewswire October 12, 2020

DEADLINE ALERT for GOCO, NXTC, WRTC, GLNG: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire October 12, 2020

NXTC INVESTOR ALERT: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.

ACCESSWIRE IA October 12, 2020

Rosen, Global Investor Counsel, Reminds NextCure, Inc. Investors of Important Deadline in Securities Class Action - NXTC

Newsfile October 12, 2020

ROSEN, A LEADING NATIONAL LAW FIRM, Reminds NextCure, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - NXTC

PR Newswire October 9, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NextCure, Inc. - NXTC

GlobeNewswire October 9, 2020

Portnoy Law: Lawsuit Filed On Behalf of Nextcure, Inc. Investors

GlobeNewswire October 8, 2020

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against NextCure, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA October 8, 2020

DEADLINE REMINDER: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NextCure, Inc. (NXTC)

PR Newswire October 8, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NextCure, Inc. - NXTC

ACCESSWIRE IA October 6, 2020

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against NextCure, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA October 6, 2020

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of NextCure, Inc. (NXTC) Investors

PR Newswire October 6, 2020

NXTC Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NextCure, Inc. Investors of Class Action and Encourages Investors to Contact the Firm

ACCESSWIRE IA October 6, 2020

NXTC INVESTOR ALERT: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.

ACCESSWIRE IA October 6, 2020

ROSEN, A LEADING LAW FIRM, Reminds NextCure, Inc. Investors of Important November 20 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - NXTC

Business Wire October 5, 2020

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against NextCure, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA October 5, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NextCure, Inc. - NXTC

ACCESSWIRE IA October 3, 2020

Rosen, Globally Respected Investor Counsel, Announces Filing of Securities Class Action Lawsuit Against NextCure, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - NXTC

Newsfile October 2, 2020

ONE STOCK SYMBOL INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against NextCure, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA October 2, 2020

NXTC Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NextCure, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

Business Wire October 2, 2020